title: The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus.
abstract: OBJECTIVE
  To evaluate, in premenopausal systemic lupus erythematosus (SLE) patients, the possible protective role of androgens on bone mass.
  
  
  METHODS
  Bone mineral density (BMD) was measured in the lumbar spine and femoral neck in 37 women with SLE (mean age 31.1 years) without disturbances or therapy that could interfere with bone metabolism except glucocorticoid therapy. We measured serum intact parathyroid hormone (iPTH): 2.5 +/- 1.3 pmol/L, serum testosterone: 1.6 +/- 1.1 nmol/L, salivary testosterone: 0.09 +/- 0.1 nmol/L, and serum dehydroepiandrosterone sulphate (DHEAS): 2.2 +/- 2.2 umol/L.
  
  
  RESULTS
  BMD in the spine (L2-L4) was 0.94 +/- 0.1 g/cm2 and in the femoral neck 0.77 +/- 0.1 g/cm2. Four patients (10.8%) had osteoporosis. We found a significant positive relationship between DHEAS and BMD, a negative relationship between DHEAS and the glucocorticoid dose at the time of study, and a negative correlation between iPTH and DHEAS.
  
  
  CONCLUSIONS
  Bone loss in corticosteroid-treated premenopausal patients with SLE may be modulated through down-regulation of the endogenous production of DHEAS.
authors.affiliation: Internal Medicine Service, Hospital Princeps d'Espanya CSU de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Formiga
authors.forename: I
authors.initials: I
authors.lastname: Moga
authors.forename: J M
authors.initials: JM
authors.lastname: Nolla
authors.forename: M A
authors.initials: MA
authors.lastname: Navarro
authors.forename: R
authors.initials: R
authors.lastname: Bonnin
authors.forename: D
authors.initials: D
authors.lastname: Roig-Escofet
mesh_terms: D000328:Adult; D015519:Bone Density; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000188:drug therapy; D010024:Osteoporosis / Q000139:chemically induced; D010281:Parathyroid Hormone / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D017697:Premenopause; D012463:Saliva / Q000737:chemistry; D013739:Testosterone / Q000097:blood
chemical_list: D005938:Glucocorticoids; D010281:Parathyroid Hormone; D013739:Testosterone; D019314:Dehydroepiandrosterone Sulfate; D011241:Prednisone